Advances in Familial Hypercholesterolemia Identification and Management: Clinical Concepts and Expert Insights
Time to complete: 1 Hour
- 1.0 AMA PRA Category 1 Credit(s)™
Overview: This interactive CME initiative explores strategies for recognizing the risk of familial hypercholesterolemia (FH) and accurately diagnosing the disease based on contemporary clinical practice guidelines. The activity also includes a discussion of current evidence- and guideline-based treatment strategies, as well as an in-depth look at evolving management strategies. Integrated audio segments are also included to highlight expert faculty perspectives regarding the role of cascade screening, the relationship between genetics and treatment in FH, and the potential application of new and emerging therapies.
Peter P. Toth, MD, PhD
James Underberg, MD, MS, FACPM, FACP, FASH, FNLA
Non-Credit Supplemental Educational Material:
Note: This material is not CME certified and, therefore, does not offer any CME/CE credit.
This activity has been approved for AMA PRA Category 1 Credit™.
This activity is supported by an educational grant from Genzyme, a Sanofi company.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.